Stomach cancer. clinical significance of the expression of key components of pd-1/pd-l1 immune checkpoint

被引：0
|
作者：
Kovaleva, Olga V. [1 ]
Podlesnaya, Polina A. [1 ]
Gratchev, Alexei N. [1 ]
Chang, Victor L. [2 ]
Ognerubov, Nikolai A. [2 ,3 ]
Kushlinskii, Nikolai E. [1 ]
机构：
[1] Blokhin National Medical Research Center of Oncology, Moscow, Russia
[2] Derzhavin Tambov State University, Tambov, Russia
[3] Tambov Regional Oncological Clinical Dispensary, Tambov, Russia
来源：
Journal of Nonlinear and Variational Analysis | 2021年 / 5卷 / 03期
关键词：
59;
D O I：
10.26442/18151434.2021.1.200749
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：122 / 127
相关论文
共 50 条
  • [1] Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Akagi, Masao
    DIAGNOSTICS, 2020, 10 (08)
  • [2] Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance
    Yusof, Mohd Nazzary Mamat
    Chew, Kah Teik
    Kampan, Nirmala Chandralega
    Shafiee, Mohamad Nasir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [3] The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
    Wang, Qingshui
    Lin, Wei
    Tang, Xiaoqiong
    Li, Suhuan
    Guo, Libin
    Lin, Yao
    Kwok, Hang Fai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [4] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [5] Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
    Semra Paydas
    Emine Kilic Bagir
    Mehmet Ali Deveci
    Gulfiliz Gonlusen
    Medical Oncology, 2016, 33
  • [6] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [7] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [8] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [9] Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
    Paydas, Semra
    Bagir, Emine Kilic
    Deveci, Mehmet Ali
    Gonlusen, Gulfiliz
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [10] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
12345